Evaluation of the efficacy of Sitagliptin plus peginterferon alfa 2b /ribavirin combination therapy in CHC patients with insulin resistance
Not Applicable
- Conditions
- Hepatitis C
- Registration Number
- JPRN-UMIN000003957
- Lead Sponsor
- Hyogo College Of Medicine
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Complete: follow-up complete
- Sex
- All
- Target Recruitment
- 60
Inclusion Criteria
Not provided
Exclusion Criteria
1) Pregnant , possibly pregnant or lactating women 2) Patients with severe heart diseases 3) Chronic kidney failure or creatinine clearance of <=50 mL/min 4) Current or history of severe psychiatric disorder 5) Autoimmune hepatitis 6) Intolerance to sitagliptin 7) medication for diabetes
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method SVR rate
- Secondary Outcome Measures
Name Time Method HOMA-IR decrease safet